Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought

J. Palou, F. Pisano, R. Sylvester, S. Joniau, V. Serretta, S. Larré, S. Di Stasi, B. van Rhijn, A. J. Witjes, A. Grotenhuis, R. Colombo, A. Briganti, M. Babjuk, V. Soukup, P. U. Malmstrom, J. Irani, N. Malats, J. Baniel, R. Mano, T. CaiE. K. Cha, P. Ardelt, J. Varkarakis, R. Bartoletti, G. Dalbagni, S. F. Shariat, E. Xylinas, R. J. Karnes, P. Gontero

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought'. Together they form a unique fingerprint.

Medicine & Life Sciences